EVM
IRWD icon

Eaton Vance Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Eaton Vance Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-16,716
Closed -$214K – 941
2014
Q4 		$214K Sell
16,716
-1,245
-7% -$14.2K ﹤0.01% 883
2014
Q3 		$195K Hold
17,961
– – ﹤0.01% 876
2014
Q2 		$231K Hold
17,961
– – ﹤0.01% 863
2014
Q1 		$185K Sell
17,961
-4,419
-20% -$49.7K ﹤0.01% 857
2013
Q4 		$218K Buy
+22,380
New +$201K ﹤0.01% 836

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Eaton Vance Management's IRWD Position: Q1 2015 in Review

Eaton Vance Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 16,716 shares — an estimated $214K sold.

Eaton Vance Management first reported a position in IRWD in Q4 2013 and held it in 5 quarters. The position peaked at $231K in Q2 2014. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

  • Eaton Vance Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Eaton Vance Management sold 16,716 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $214K.
  • Eaton Vance Management first reported a position in Ironwood Pharmaceuticals in Q4 2013 and held it in 5 quarters.
  • Eaton Vance Management's Ironwood Pharmaceuticals position peaked at $231K in Q2 2014.
  • 142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on Eaton Vance Management's 13F filing for Q1 2015, filed 11 May 2015.